AI-Powered NGS & Personalized Medicine

BayBifx and SeqOne will be at Myriad Genetics!
Learn how AI-Powered NGS BioInformatics is Driving Personalized medicine! This session will focus on variant interpretation and prioritization for disease diagnostics.

About SeqOne
SeqOne is redefining NGS analysis with its cutting-edge bioinformatics platform designed for molecular labs. This exclusive session will explore how its revolutionary AI variant prioritization tool is transforming inherited disease diagnostics and unveil the latest innovations advancing oncology applications. Smarter genomics. Faster insights. Greater confidence. See what’s next.

Speakers:

• AJ Sura – Senior Account Executive, Western U.S. & Canada, with extensive experience at Velsera, Strand Life Sciences, and GenomOncology, bringing deep industry knowledge in NGS precision medicine.
• Christophe Meynier, PhD – VP of Sales, with deep experience in global NGS and bioinformatics business development, having worked with Illumina, Eurofins, Tecan, and Nostos.
• Alexander Kurze, PhD – COO, an expert in precision medicine and oncology NGS, formerly at SOPHiA GENETICS and co-founder of Zyme Dx.
• Aneesa Al-Soodani, PhD – Clinical Genomics Scientist, Myriad Genetics